These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11045979)

  • 1. Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy.
    Evans CC; Pena JR; Phillips RM; Muthuchamy M; Wieczorek DF; Solaro RJ; Wolska BM
    Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2414-23. PubMed ID: 11045979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosis.
    Sheehan KA; Arteaga GM; Hinken AC; Dias FA; Ribeiro C; Wieczorek DF; Solaro RJ; Wolska BM
    J Mol Cell Cardiol; 2011 Mar; 50(3):442-50. PubMed ID: 21047515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between myofilament response to Ca2+ and altered dynamics of contraction and relaxation in transgenic cardiac cells that express beta-tropomyosin.
    Wolska BM; Keller RS; Evans CC; Palmiter KA; Phillips RM; Muthuchamy M; Oehlenschlager J; Wieczorek DF; de Tombe PP; Solaro RJ
    Circ Res; 1999 Apr; 84(7):745-51. PubMed ID: 10205142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
    Gaffin RD; Peña JR; Alves MS; Dias FA; Chowdhury SA; Heinrich LS; Goldspink PH; Kranias EG; Wieczorek DF; Wolska BM
    J Mol Cell Cardiol; 2011 Nov; 51(5):812-20. PubMed ID: 21840315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tropomyosin-κ induces dilated cardiomyopathy and depresses cardiac myofilament tension by mechanisms involving cross-bridge dependent activation and altered tropomyosin phosphorylation.
    Karam CN; Warren CM; Rajan S; de Tombe PP; Wieczorek DF; Solaro RJ
    J Muscle Res Cell Motil; 2011 Mar; 31(5-6):315-22. PubMed ID: 21221740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.
    Jagatheesan G; Rajan S; Petrashevskaya N; Schwartz A; Boivin G; Arteaga GM; Solaro RJ; Liggett SB; Wieczorek DF
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H949-58. PubMed ID: 17416600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.
    Peña JR; Szkudlarek AC; Warren CM; Heinrich LS; Gaffin RD; Jagatheesan G; del Monte F; Hajjar RJ; Goldspink PH; Solaro RJ; Wieczorek DF; Wolska BM
    J Mol Cell Cardiol; 2010 Dec; 49(6):993-1002. PubMed ID: 20854827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an alpha-tropomyosin mutation linked to familial hypertrophic cardiomyopathy.
    Burkart EM; Arteaga GM; Sumandea MP; Prabhakar R; Wieczorek DF; Solaro RJ
    J Mol Cell Cardiol; 2003 Oct; 35(10):1285-93. PubMed ID: 14519438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An internal domain of beta-tropomyosin increases myofilament Ca(2+) sensitivity.
    Jagatheesan G; Rajan S; Schulz EM; Ahmed RP; Petrashevskaya N; Schwartz A; Boivin GP; Arteaga GM; Wang T; Wang YG; Ashraf M; Liggett SB; Lorenz J; Solaro RJ; Wieczorek DF
    Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H181-90. PubMed ID: 19429821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T.
    Chandra M; Rundell VL; Tardiff JC; Leinwand LA; De Tombe PP; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H705-13. PubMed ID: 11158969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N.
    Gaffin RD; Chowdhury SA; Alves MS; Dias FA; Ribeiro CT; Fogaca RT; Wieczorek DF; Wolska BM
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1646-55. PubMed ID: 21743000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions.
    Wolska BM; Vijayan K; Arteaga GM; Konhilas JP; Phillips RM; Kim R; Naya T; Leiden JM; Martin AF; de Tombe PP; Solaro RJ
    J Physiol; 2001 Nov; 536(Pt 3):863-70. PubMed ID: 11691878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKA accelerates rate of force development in murine skinned myocardium expressing alpha- or beta-tropomyosin.
    Patel JR; Fitzsimons DP; Buck SH; Muthuchamy M; Wieczorek DF; Moss RL
    Am J Physiol Heart Circ Physiol; 2001 Jun; 280(6):H2732-9. PubMed ID: 11356630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation.
    Scruggs SB; Hinken AC; Thawornkaiwong A; Robbins J; Walker LA; de Tombe PP; Geenen DL; Buttrick PM; Solaro RJ
    J Biol Chem; 2009 Feb; 284(8):5097-106. PubMed ID: 19106098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.
    Michele DE; Gomez CA; Hong KE; Westfall MV; Metzger JM
    Circ Res; 2002 Aug; 91(3):255-62. PubMed ID: 12169652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
    Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
    Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charged residue changes in the carboxy-terminus of alpha-tropomyosin alter mouse cardiac muscle contractility.
    Gaffin RD; Gokulan K; Sacchettini JC; Hewett T; Klevitsky R; Robbins J; Muthuchamy M
    J Physiol; 2004 Apr; 556(Pt 2):531-43. PubMed ID: 14766940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Na+/Ca2+ exchanger gene attenuates postinfarction myocardial dysfunction.
    Min JY; Sullivan MF; Yan X; Feng X; Chu V; Wang JF; Amende I; Morgan JP; Philipson KD; Hampton TG
    Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2466-71. PubMed ID: 12388257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in end-to-end interactions of tropomyosin affect mouse cardiac muscle dynamics.
    Gaffin RD; Gokulan K; Sacchettini JC; Hewett TE; Klevitsky R; Robbins J; Sarin V; Zawieja DC; Meininger GA; Muthuchamy M
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H552-63. PubMed ID: 16501024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.